08.11.2006 – 08:03

Marseille-Kliniken AG

euro adhoc: Marseille-Kliniken AG
quarterly or semiannual financial statement / - Turnover increase to 52.8 million Euro in the first quarter of 2006/2007 - Company’s DVFA/SG adjusted result increases above-average by 0.4 million Euro to 3.6 million Eu

  Disclosure announcement transmitted by euro adhoc. The issuer is responsible
  for the content of this announcement.

08.11.2006

Berlin, 8th November 2006. The Marseille-Kliniken AG (Prime Standard,
ISIN DE 0007783003, MKA)  continues improving its results in an
above-average way. In the first quarter of the current financial year
(01.07.2006 - 30.09.2006) the company turnover was increased to 52.8
million Euro (previous year: 51.5 million Euro). At 3.6 million Euro,
the DVFA result within the company is a total of 0.4 million Euro
above the level of the previous year. Per share this is equal to a
result increase of 0.03 Euro to 0.30 Euro (previous year: 0.27 Euro).

The growth comes from the elderly care sector in which the turnover
has increased from 39.3 million Euro in the previous year to 40.3
million Euro, which is an increase of 2.5 %. The rise is a result of
the expansion of bed capacities and the utilisation increase
resulting from the specialisations in stock in individual facilities.
The bed capacity of the nursing sector was increased by the deadline
by 474 beds to 7134 beds (previous year: 6660 beds). Therefore within
the company the total capacity rose to 8612 beds (previous year: 8169
beds). At 4.2 million Euro the DVFA/SG (IFRS) adjusted result was 0.3
million Euro higher than in the previous year. The utilisation rate
was increased to 92.6 % by 0.9 % points due to targeted marketing
activities. So overall with 89.7 % the company’s utilisation rate was
above 89.1 %, which was the level of the previous year.

The optimisation measures in the rehabilitation sector are taking
hold. Although according to plan the bed capacity in this sector was
reduced by 1509 beds in the previous year to now 1478 beds, the sales
revenue of 12.2 million Euro has seen a slight increase by 2.5 % to
12.5 million Euro and the DVFA result with -0.6 million Euro was
retained at the level of the previous year. Therefore this can be
considered as a particular success, as the rehabilitation sector was
burdened by the repercussions of the doctors’ strikes in the first
quarter. This also explains the decrease in utilisation, which
reduced from 79.2 % to 76.7 % in the remaining clinics in the
quarterly comparison. The utilisation rate lies clearly above the
average value of the whole year of 2005/2006 of 74.2 %.

For the rest of the financial year 2006/2007 the company is planning
above-average turnover and result growth in comparison to the
previous year. The already apparent positive occupancy development in
the nursing sector will have great effects in the third and fourth
quarters. We are consistently putting our growth strategy into
action; another 1000 beds have already been contractually guaranteed.
The sale of individual clinics in the rehabilitation sector will be
intensively pushed. Due to the implementation of different
optimisation measures from this sector the company is expecting an
improvement in results.

End of the ad hoc release

end of announcement                               euro adhoc 08.11.2006 07:26:05

Further inquiry note:

If you have any questions please contact:

Marseille-Kliniken AG Hillermann Consulting
Axel Hölzer Christian Hillermann
CEO Investor Relations
Alte Jakobstraße 79/80 Eppendorfer Baum 5
10709 Berlin 20249 Hamburg
Tel.: 030 / 246 32-400 Tel.: 040 / 414 069-13
Fax: 030 / 246 32-401 Fax: 040 / 414 069-14

Branche: Pharmaceuticals
ISIN: DE0007783003
WKN: 778300
Index: CDAX, Classic All Share, Prime All Share
Börsen: Frankfurter Wertpapierbörse / official dealing/prime standard
Börse Berlin-Bremen / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Hamburger Wertpapierbörse / official dealing